Corient Private Wealth’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$48.2M Sell
560,236
-793,646
-59% -$76M 0.07% 244
2025
Q4
$113M Buy
1,353,882
+789,852
+140% +$76.7M 0.08% 224
2025
Q3
$53.7M Sell
564,030
-394,987
-41% -$36.3M 0.08% 220
2025
Q2
$83.6M Buy
959,017
+347,435
+57% +$29.5M 0.11% 175
2025
Q1
$55M Sell
611,582
-7,557
-1% -$676K 0.09% 207
2024
Q4
$49.5M Sell
619,139
-32,853
-5% -$2.84M 0.08% 229
2024
Q3
$58.7M Sell
651,992
-36,969
-5% -$3.11M 0.09% 212
2024
Q2
$54.2M Buy
688,961
+26,117
+4% +$2.14M 0.09% 214
2024
Q1
$57.8M Buy
662,844
+55,601
+9% +$4.75M 0.1% 204
2023
Q4
$50M Buy
607,243
+45,517
+8% +$3.47M 0.09% 217
2023
Q3
$44M Sell
561,726
-9,980
-2% -$835K 0.1% 214
2023
Q2
$50.4M Buy
571,706
+146,234
+34% +$12.6M 0.12% 184
2023
Q1
$34.3M Buy
425,472
+199,553
+88% +$16.3M 0.09% 215
2022
Q4
$17.6M Buy
+225,919
New +$18.3M 0.06% 287

Other funds holding MDT

Corient Private Wealth's MDT Position: Q1 2026 in Review

Corient Private Wealth reduced its Medtronic (MDT) stake by 59% in Q1 2026, selling an estimated $76M and leaving 560,236 shares worth $48.2M. The position accounts for 0.07% of the portfolio, ranked #244.

Corient Private Wealth first reported a position in MDT in Q4 2022 and has held it in 14 quarters since. The position peaked at $113M in Q4 2025. 2,229 funds tracked by Wall St. Rank hold MDT as of Q1 2026.

  • Corient Private Wealth held 560,236 shares of Medtronic worth $48.2M as of Q1 2026.
  • Corient Private Wealth sold 793,646 Medtronic shares in Q1 2026, an estimated $76M.
  • Medtronic made up 0.07% of Corient Private Wealth's portfolio in Q1 2026, its #244 holding.
  • Corient Private Wealth first reported a position in Medtronic in Q4 2022 and has held it in 14 quarters since.
  • Corient Private Wealth's Medtronic position peaked at $113M in Q4 2025.
  • 2,229 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.

Based on Corient Private Wealth's 13F filing for Q1 2026, filed 15 May 2026.